Solid Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Solid Biosciences

14/08/2023 23:08

* Solid Biosciences Inc  SLDB.OQ  reported a quarterly
adjusted
loss of $1.25​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of $1.53 per share.
    * Reported revenue was zero​; analysts expected $1.47
million. 
    * Solid Biosciences Inc's reported EPS for the quarter was a
loss
of $1.25​.
    * The mean earnings estimate of analysts had risen by
about 6.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Solid Biosciences Inc shares had fallen by 27.5% this
quarter and lost 29.4% so far this year.
    * The company reported a quarterly loss of $24.63 million.
    * Wall Street's median 12-month price target for Solid
Biosciences
Inc is $8.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 10:08 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.53          -1.25          Beat
 Mar. 31 2023      -2.05          -1.50          Beat
 Dec. 31 2022      -1.65          -2.82          Missed
 Sep. 30 2022      -2.67          -2.71          Missed